HGFK1 INHIBITS BONE METASTASIS IN BREAST CANCER THROUGH THE TAK1/P38 MAPK SIGNALING PATHWAY

被引：0
|
作者：
Bu, Y-Z. [1 ]
Shen, Z. [2 ]
机构：
[1] Lianshui Peoples Hosp, Dept Surg, Lianshui, Jiangsu, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
    Yao, Y.
    Fang, Z-P
    Chen, H.
    Yue, L.
    Min, D-I
    Tang, L-N
    Yu, W-X
    Kung, H. F.
    Lin, M. C.
    Shen, Z.
    CANCER GENE THERAPY, 2012, 19 (09) : 601 - 608
  • [2] HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
    Y Yao
    Z-P Fang
    H Chen
    L Yue
    D-l Min
    L-N Tang
    W-X Yu
    H F Kung
    M C Lin
    Z Shen
    Cancer Gene Therapy, 2012, 19 : 601 - 608
  • [3] p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion
    Hong, Bangxing
    Li, Haiyan
    Zhang, Mingjun
    Xu, Jingda
    Lu, Yong
    Zheng, Yuhuan
    Qian, Jianfei
    Chang, Jeffrey T.
    Yang, Jing
    Yi, Qing
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 34 - 43
  • [4] CCN6 Modulates BMP Signaling via the Smad-Independent TAK1/p38 Pathway, Acting to Suppress Metastasis of Breast Cancer
    Pal, Anupama
    Huang, Wei
    Li, Xin
    Toy, Kathy A.
    Nikolovska-Coleska, Zaneta
    Kleer, Celina G.
    CANCER RESEARCH, 2012, 72 (18) : 4818 - 4828
  • [5] Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway
    Li, Peng
    Lin, Zhiping
    Liu, Qianzheng
    Chen, Siyuan
    Gao, Xiang
    Guo, Weixiong
    Gong, Fan
    Wei, Jinsong
    Lin, Hao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Xing, Mengying
    Yang, Ying
    Huang, Jiaxue
    Fang, Yaqun
    Jin, Yucui
    Li, Lingyun
    Chen, Xiang
    Zhu, Xiaoxia
    Ma, Changyan
    GENES & GENOMICS, 2022, 44 (07) : 801 - 812
  • [7] TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
    Mengying Xing
    Ying Yang
    Jiaxue Huang
    Yaqun Fang
    Yucui Jin
    Lingyun Li
    Xiang Chen
    Xiaoxia Zhu
    Changyan Ma
    Genes & Genomics, 2022, 44 : 801 - 812
  • [8] Identification of novel TAK1 and p38 MAPK dependent phosphorylation sites in TAB1, a regulatory subunit of the protein kinase TAK1
    Wolf, A.
    Vahlsing, S.
    Dittrich-Breiholz, O.
    Schneider, H.
    Beuerlein, K.
    Kracht, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 29 - 29
  • [9] Holothurin A Inhibits RUNX1-Enhanced EMT in Metastasis Prostate Cancer via the Akt/JNK and P38 MAPK Signaling Pathway
    Janta, Sirorat
    Pranweerapaiboon, Kanta
    Vivithanaporn, Pornpun
    Plubrukarn, Anuchit
    Chairoungdua, Arthit
    Prasertsuksri, Prachayaporn
    Apisawetakan, Somjai
    Chaithirayanon, Kulathida
    MARINE DRUGS, 2023, 21 (06)
  • [10] Senescent retinal pigment epithelial cells promote angiogenesis in choroidal neovascularization via the TAK1/p38 MAPK pathway
    Wang, Yinhao
    Ma, Huiling
    Yang, Qianjie
    Chen, Kuangqi
    Ye, Hui
    Wang, Xinglin
    Xia, Jianhua
    Chen, Xiaodan
    Wang, Xiawei
    Shen, Ye
    Cui, Hongguang
    EXPERIMENTAL EYE RESEARCH, 2025, 251
12345